Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$207.02 - $241.31 $456,893 - $532,571
-2,207 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$207.01 - $276.09 $235,991 - $314,742
-1,140 Reduced 34.06%
2,207 $522,000
Q3 2020

Nov 13, 2020

BUY
$255.65 - $303.1 $239,544 - $284,004
937 Added 38.88%
3,347 $911,000
Q2 2020

Aug 14, 2020

SELL
$225.48 - $295.8 $609,923 - $800,139
-2,705 Reduced 52.88%
2,410 $700,000
Q1 2020

May 13, 2020

SELL
$199.77 - $247.81 $452,479 - $561,289
-2,265 Reduced 30.69%
5,115 $1.22 Million
Q4 2019

Feb 12, 2020

SELL
$166.71 - $223.91 $174,545 - $234,433
-1,047 Reduced 12.42%
7,380 $1.62 Million
Q3 2019

Nov 15, 2019

BUY
$166.23 - $187.09 $16,290 - $18,334
98 Added 1.18%
8,427 $1.43 Million
Q2 2019

Aug 15, 2019

BUY
$164.61 - $190.37 $130,371 - $150,773
792 Added 10.51%
8,329 $1.53 Million
Q1 2019

May 10, 2019

BUY
$163.73 - $194.7 $548,004 - $651,660
3,347 Added 79.88%
7,537 $1.39 Million
Q4 2018

Feb 13, 2019

SELL
$151.91 - $192.21 $99,501 - $125,897
-655 Reduced 13.52%
4,190 $694,000
Q3 2018

Nov 09, 2018

BUY
$167.73 - $192.74 $160,182 - $184,066
955 Added 24.55%
4,845 $934,000
Q2 2018

Aug 06, 2018

BUY
$145.72 - $169.96 $566,850 - $661,144
3,890 New
3,890 $661,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bank Of Hawaii Portfolio

Follow Bank Of Hawaii and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Hawaii, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Hawaii with notifications on news.